3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
47
Liver Neoplasms
22
Stomach Neoplasms
11
Neoplasm Metastasis
9
Colorectal Neoplasms
9
Sarcoma
6
Pancreatic Neoplasms
6
Neoplasms
6
Colonic Neoplasms
6
Breast Neoplasms
6
Ovarian Neoplasms
5
Hepatoblastoma
5
Rectal Neoplasms
3
Prostatic Neoplasms
3
Peritoneal Neoplasms
3
Lymphoma, Non-Hodgkin
3
Appendiceal Neoplasms
3
Uterine Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Mesothelioma, Malignant
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
sodium thiosulfate
1
X-Rays
1
Surveys and Questionnaires
1
Specimen Handling
1
Platinum
1
Particle Accelerators
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Hyperthermic Intraperitoneal Chemotherapy
1
Doxorubicin
1
Device Removal
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Blood Coagulation Tests
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pelvic Neoplasms
×
Doxorubicin
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled